Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia

Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia

Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leukemia, the problem of toxicity of high-intensity t...

Full description

Bibliographic Details
Main Authors: E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Format: Article
Language:Russian
Published: Private institution educational organization of higher education "Medical University "ReaViz" 2023-01-01
Series:Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:
острый миелоидный лейкоз
гипометилирующие агенты и венетоклакс
анализ эффективности и общей выживаемости
гематологическая токсичность
инфекционные осложнения
covid-19
Online Access:https://vestnik.reaviz.ru/jour/article/view/565

Internet

https://vestnik.reaviz.ru/jour/article/view/565

Similar Items